Introduction: Rifampicin is a potent antitubercular drug used in the treatment of tuberculosis (TB). It is known to cause nephrotoxicity of which nephrotic syndrome is a less common though well-known manifestation.
INTRODUCTION
Rifampicin is an essential antitubercular drug used as first-line treatment of tuberculosis. It is known to cause nephrotoxicity [1] [2] [3] [4] [5] [6] [7] [8] [9] mostly in the form of acute interstitial nephritis or acute tubular necrosis and less commonly as rapidly progressive glomerulonephritis 9,10 or nephrotic syndrome. 2, [5] [6] [7] [8] Drug-induced minimal change disease responds well to drug withdrawal and steroid therapy .1, 11 We present a case of rifampicin induced MCD in an human immunodeficiency virus (HIV) patient who responded to drug withdrawal alone and recovered completely without any other therapeutic intervention.
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CASE REPORT
A 32-year-old army personnel presented with fever and significant weight loss of two months duration. Anti hepatitis C virus (HCV) antibodies were positive though HCV Ribonucleic acid (RNA) was undetectable and repeat HCV antibodies turned negative after six months. His HIV RNA was 100 copies per ml. A kidney biopsy revealed a nonproliferative glomerulopathy with no significant glomerular immune deposits, no evidence of segmental sclerosis or any crescent formation and insignificant interstitial fibrosis and tubular atrophy. Rifampicin-induced Minimal change disease was suspected, and he was switched from Rifampicin to Rifabutin and started on angiotensin-converting enzyme -I (ACE-I). He was followed up with no other intervention. Proteinuria regressed to 760 mg per day after one month and was 206 mg per day at six months of rifampicin withdrawal. Serum albumin levels returned to normal within 6 weeks. His ammonia tolerance test (ATT) was stopped after 6 months and there is no recurrence of significant proteinuria on follow up at twelve months.
DISCUSSION
Rifampicin is an antitubercular drug used as an essential component of first-line antitubercular therapy. It is associated with several forms of nephrotoxicity. [2] [3] [4] [5] [6] [7] [8] [9] [10] The most common form of rifampicin induced renal injury is acute allergic interstitial nephritis and acute tubular necrosis. The latter is often though not always associated with CASE REPORT JOMA autoimmune hemolytic anemia with hemoglobinuria and thrombocytopenia. Less commonly it presents with rapidly progressive renal failure, 9,10 light chain proteinuria 4 or frank nephrotic syndrome.
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Our patient presented with nephrotic range proteinuria and hypoalbuminemia approximately 7 weeks after starting antitubercular therapy and 5 weeks after AR . Although tenofovir is well known to cause tubular toxicity, it does not present with nephrotic syndrome. We ruled out all other common secondary causes of nephrotic syndrome in our patient. There was no other significant past medical history or history of any other drug intake. We suspected Rifampicin induced nephrotic syndrome which was confirmed by rapid regression of proteinuria with drug withdrawal.
Although there are no definite mechanisms offered for Rifampicin induced MCD, a hypersensitivity mechanism has been suggested in many drug-induced MCD cases wherein the drug exposure induces activation of inflammatory or immune cells causing glomerular injury and MCD. 12 Another possible mechanism of MCD is via direct toxin effect on glomerular epithelial cells resulting in abnormal permeability and effacement of foot processes. 12 Neugarten et al. 6 reported a case of a rifampicin induced nephrotic syndrome and described the patient as having acute interstitial nephritis with heavy proteinuria and effacement of glomerular epithelial cells. They suggested that cell-mediated and humoral immune response to rifampicin therapy could lead to the development of glomerular injury and nephrotic syndrome. In our case, there was no significant glomerular immune deposits or immune complex-mediated glomerular injury. Hence direct toxin effects due to drug exposure are the is the likely mechanism of MCD in this case. In many cases withdrawal of the offending drug can lead to complete remission of proteinuria and glucocorticoids may hasten recovery and remission of proteinuria. 12 We came across few cases of rifampicin induced MCD treated with drug withdrawal and a short course of glucocorticoids with complete recovery. 7 However as in our patient there is only one other case report of rifampicin induced MCD where the patient recovered completely with drug withdrawal alone. 13 Hence we suggest a wait and watch approach in a case of rifampicin induced minimal change disease with drug withdrawal alone and steroid therapy may only be considered in those cases where drug withdrawal alone does not ameliorate proteinuria adequately. Also, rifabutin was well tolerated as a substitute to rifampicin in our patient as an alternative to rifampicin and did not lead to recurrence of proteinuria.
